The prevalence of homozygote, heterozygote and pathological homozygote for the eNOSG894T polymorphism in VTE patients was 79.7%, 18.1% and 2.2%, respectively (controls: 86.6%，12.3% and 1.1%).
To determine whether the polymorphic dinucleotide repeats found in intron 4 of the endothelial cell nitric oxide synthase (ecNOS) gene and the platelet GPIIIa PLA(1)/A(2) polymorphism are associated with myocardial infarction (MI) and venous thromboembolism (VTE) in African Americans.